Showing results (1-10 of 126) with videos related to
Sort By:
Pageof 13
Recent Patents on Anti-Infective Drug Discovery|January 29, 2008
Dendrimer based anti-infective and anti-inflammatory drugsPeter M H Heegaard, Ulrik BoasBioconjugate Chemistry|November 6, 2009
Dendrimers for vaccine and immunostimulatory uses. A reviewPeter M H Heegaard, Ulrik Boas, Nanna Skall SorensenMacromolecular Bioscience|June 28, 2007
Dendrimer effects on peptide and protein fibrillationPeter M H Heegaard, Ulrik Boas, Daniel E OtzenMacromolecular Bioscience|November 5, 2011
Enhancement of muramyldipeptide (MDP) immunostimulatory activity by controlled multimerization on dendrimersNanna S Sorensen, Ulrik Boas, Peter M H HeegaardBiomacromolecules|October 9, 2007
Guanidino- and urea-modified dendrimers as potent solubilizers of misfolded prion protein aggregates under non-cytotoxic conditions. dependence on dendrimer generation and surface chargeHenriette Cordes, Ulrik Boas, Panchale Olsen, et al.FEBS Letters|November 6, 2004
Amyloid aggregates of the prion peptide PrP106-126 are destabilised by oxidation and by the action of dendrimersPeter M H Heegaard, Heidi Gertz Pedersen, James Flink, et al.Journal of Immunological Methods|February 25, 2009
A robust quantitative solid phase immunoassay for the acute phase protein C-reactive protein (CRP) based on cytidine 5'-diphosphocholine coupled dendrimersPeter M H Heegaard, Heidi G Pedersen, Asger Lundorff Jensen, et al.Biopolymers|January 19, 2008
Dendrimers destabilize proteins in a generation-dependent manner involving electrostatic interactionsLise Giehm, Casper Christensen, Ulrik Boas, et al.Biomacromolecules|November 25, 2014
Urea and thiourea modified polypropyleneimine dendrimers clear intracellular α-synuclein aggregates in a human cell lineKristoffer Laumann, Ulrik Boas, Hjalte M Larsen, et al.Pageof 13